Coloplast As Sp/Adr

Ladies and gentlemen, welcome to the Coloplast Interim Financial Statement for H1 2025-26 Conference Call. I'm Lorenzo, the Chorus Call Operator. I would like to remind you that all participants will be in listen-only mode and the conference is being recorded. The presentation will be followed by a Q&A session. You can register for questions at any time by pressing star and 1 on your telephone. For operator assistance, please press star and 0 The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Andras Loning-Skovkart, Executive Vice President and CFO.

Please go ahead, sir. Thank you. I'm Anders Lange Skogård, CFO of Coloplast, and I'm very happy to introduce our new president and CEO, Gavin Wood, who joined the company on May 1st. Please turn to slide number three.

Thank you, Anders, and good morning, everyone. As Anders mentioned, I joined Coloplast on May 1st, and this is my first opportunity to speak with many of you. So let me briefly introduce myself and share what excites me about joining Coloplast for this next chapter. I've spent more than two decades in global medtech, leading commercial organizations and multibillion-dollar businesses across different regions and therapeutic areas. Most recently, I served as company group chair of Johnson & Johnson MedTech, Ameya, with an organization of more than 7,000 employees and ownership across surgery, orthopedics, and cardiovascular solutions. Prior to this, I was the worldwide president of Ethicon's wound closure and healing business, and before that, the executive vice president of global commercial at Monlica. I started my MedTech career as a sales rep, at Ethicon Endosurgery, followed by a series of traditional roles across sales and sales management. It was there that I first saw the impact a medical device can have when it's used by a physician on a patient or a customer. And that experience is what really attracted me to the medtech industry and has motivated me to stay. A bit of context on me personally. I'm Canadian by birth. currently living in Switzerland and relocating to Denmark. My career has come across multiple geographies and is shaped by a global mindset and a strong appreciation for different cultures and ways of working. As I begin this new chapter, I want to put a few words to why Coloplast and why now. First, the deep sense of purpose. Coloplast was born because a nurse saw her sister suffering and refused to accept it, and an engineer committed to bringing her idea to life. It was about solving a human problem. Second, the people. the people behind the business. Every conversation I've had has confirmed that Coloplast is full of great talent, passion, and commitment. And I can feel that. And as in any company, it's the quality of the people that ultimately determines what's possible. Third, the ambition. Coloplast wants to write its next chapter to become even more impactful towards users, customers, and communities, helping 4 million people long-term, about twice as many as we serve today. Our 2030 strategy, Impact 4, is designed to build that future by setting the standard of care at scale, anchored in deep customer centricity, and that resonates with me deeply. I'm a builder at heart, and I see something meaningful that we can achieve together. The company has a strong legacy built over many years, and as I approach this role with curiosity, genuine respect for that history at this stage for me it's all about building a perspective forming a clear view of where the future growth opportunities may lie and where the organization may need to challenge itself as we look ahead at its core this is about continuing what coloplast has done well for many years converting investment focus, and execution into strong and sustainable returns over time. The way I lead is grounded in a few simple beliefs. I believe value is created when ambition is translated into a number of clear priorities, when decisions are made as close to the customers as possible, and when teams are empowered. with accountability for outcomes. That's how consistency and momentum are built over time, and ultimately, I believe focus drives results. And this all starts with people. I place a strong emphasis on developing leaders and creating the environment where teams can perform at their best, because the culture, people, and strength of an organization ultimately determines what's possible and what we can deliver together. As I start my new role, I will be spending time close to the business, engaging across the organization, and in our key markets, deepening my understanding of the impact for and focusing on strong commercial execution from day one. This is about seeing how Coloplast operates in practice, how decisions are made, and how our teams deliver for impact for our customers each and every day. My focus is simple, building best-in-class talent to drive performance and results. And I'm looking forward to meeting many of you on the road in the coming months. Coloplast was built by listening closely to our users and our customers, and I'm excited to keep learning, listening, and building the next chapter of this company together with the people who make it possible. With that, I'll hand back to Anders, who will take us through the financial results for the quarter. Please turn to slide number four.